Gut Problems Before MS Diagnosis: The Evidence That the Disease Starts Years Earlier

Multiple sclerosis is a neurological disease.

But that does not mean the disease process suddenly begins in the brain when someone develops optic neuritis, numbness, weakness, or an abnormal MRI.

The medical records reveal a much earlier starting point.

Researchers reviewing nearly 30 years of medical records found that gut problems were already showing up more than 20 years before an MS diagnosis.

Constipation. Acid reflux. Gastritis. Bowel dysfunction and disease. Prescriptions to stimulate gut motility.

And these digestive problems became more common as people moved closer to an MS diagnosis.

That raises an important question:

Could these gut issues be early signs of the same disease process that later becomes visible in the nervous system?

For me, this is personal.

I have lived free of MS symptoms for over 37 years. Years before I was diagnosed, I had significant gut problems of my own.

At the time, I had no idea they might be connected.

Today, large health-record studies are documenting similar patterns in thousands of people who later developed MS.

The MS Story May Begin Years Before Diagnosis

Researchers use the term MS prodrome for the period before the first clear neurological symptoms of MS.

Think of it as smoke appearing before the fire alarm goes off.

The neurological attack may be the alarm.

But what was happening in the body before it?

One place researchers keep finding clues is the digestive system.

Gut Problems Were Already Showing Up Before the First Neurological Symptoms

In 2024, University of British Columbia researchers examined healthcare data from nearly 7,000 people with MS and compared them with more than 31,000 healthy controls.

They tracked doctor visits and prescriptions during the five years before the first neurological symptom.

The results were striking:

• Future MS patients were 42% more likely to see a doctor for gastritis.
• They were 46% more likely to seek care for acid reflux and esophageal problems.
• They had an 82% higher risk of needing prescription laxatives for severe constipation.
• They had a 62% higher risk of needing medications to stimulate gut motility.

These were not minor digestive complaints.

They were serious enough for people to seek medical care and require prescription treatment.

And they were happening before the first recognized neurological symptom.

Men Showed an Even Stronger Gut-Motility Pattern

One finding stood out.

Men in the pre-MS period had a 132% higher relative risk of requiring prescription motility medications compared with healthy male controls.

That matters because bowel problems in MS are often viewed mainly as a consequence of neurological damage.

But here, major motility problems were showing up years earlier.

That forces us to ask whether digestive problems may be part of the earlier MS disease timeline, not simply a complication that appears later.

A UK Study Found a Similar Pattern Over 10 Years

The Canadian findings do not stand alone.

A UK study involving about 15,000 people with MS found that during the 10 years before diagnosis, future MS patients were about twice as likely to experience bowel dysfunction, chronic pain, and mood changes.

The pattern remained even after accounting for age, income, and background.

The same broader research group has also reported prediagnostic patterns in different healthcare systems, including British Columbia, Ontario, and Sweden.

When similar patterns keep appearing across different populations, they deserve attention.

The Gut Problems Do Not Stop After Diagnosis

Digestive dysfunction remains extremely common after MS is diagnosed.

Gastroenterology reviews report that 70% to 80% of people with MS experience chronic lower gastrointestinal dysfunction, especially severe constipation.

Neurological signaling can play a role. The nervous system helps coordinate bowel movement, so disrupted signaling could impact gut motility.

But the research does not stop at constipation.

Studies also report:

• gut dysbiosis
• changes in intestinal permeability
• altered immune signaling
• Blood-Brain Barrier disruption

These findings point to a much broader gut-brain relationship.

Gut Dysbiosis Keeps Showing Up in MS

Many studies have observed gut dysbiosis in people with MS.

Dysbiosis means the microbial environment in the gut has become altered.

That matters because gut microbes do far more than help digest food.

They interact with the intestinal lining, immune system, nervous system, and inflammatory pathways throughout the body.

When the microbial environment changes, the effects may extend far beyond the digestive tract.

The Gut and Brain Are Constantly Communicating

The gut and brain communicate through what researchers call the gut-brain axis.

This involves the nervous system, immune system, hormones, blood vessels, microbial metabolites, and inflammatory signals.

Two barriers are especially important:

The intestinal barrier controls what passes from the gut into the bloodstream.

The blood-brain barrier controls what moves from the bloodstream into the central nervous system.

Both intestinal barrier disruption and blood-brain barrier disruption have been documented in MS.

Intestinal Permeability Is Part of the Picture

Researchers studying MS have reported elevated levels of zonulin, a protein involved in regulating intestinal permeability.

In MS populations, elevated zonulin has been associated with increased intestinal permeability and bacterial endotoxins found in blood samples.

This matters because when bacterial products and inflammatory compounds enter the bloodstream, they can interact with the immune system throughout the body.

In this way, the gut can become part of a broader immune and inflammatory process.

What Happens When the Blood-Brain Barrier Is Compromised?

The Blood-Brain Barrier normally protects the brain and spinal cord from substances that should not enter the central nervous system.

When that barrier becomes more permeable, unwanted substances and inflammatory cells may gain access.

The immune system then responds to protect the brain.

That raises an important question:

In MS what is the immune system responding to?

That question deserves far more attention than simply asking why the immune system is active.

Inflammation Can Damage Myelin and the Cells That Maintain It

MS involves damage to myelin, the protective covering around nerve fibers.

Oligodendrocytes are the cells that produce and maintain myelin in the central nervous system.

Inflammation in the central nervous system can damage both myelin and oligodendrocytes.

So when we look at MS, the following should not be treated as completely separate:

• gut dysbiosis
• intestinal permeability
• bacterial products in circulation
• immune activation
• Blood-Brain Barrier disruption
• central nervous system inflammation
• myelin and oligodendrocyte damage

They are all occurring in an interconnected biological system.

MS and Inflammatory Bowel Disease Keep Showing Up Together

Another clue is the overlap between MS and inflammatory gut disease.

Systematic reviews show that people with MS have about a 50% higher prevalence of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.

People with inflammatory bowel disease are also about twice as likely to develop MS.

This overlap is too significant to ignore.

IBS Is Also About Twice as Common in MS

Up to 20% of people with MS have Irritable Bowel Syndrome, approximately double the rate in the general population.

When we combine this with the prediagnosis data, dysbiosis research, intestinal permeability findings, and IBD overlap, the gut becomes increasingly difficult to dismiss as an unrelated side issue.

The Most Important Finding May Be the Timeline

This is where the research becomes especially important.

More Than 20 Years Before Diagnosis

Long-term medical records showed that digestive problems were already appearing more than 20 years before an MS diagnosis. Stomach problems, constipation, and reflux became more common as people moved closer to diagnosis.

Ten Years Before Diagnosis

A UK study involving about 15,000 people with MS found that during the decade before diagnosis, future MS patients were about twice as likely to experience bowel dysfunction, chronic pain, and mood changes.

Five Years Before the First Neurological Symptom

The 2024 UBC study then looked more closely at the five years before the first neurological symptom and found significantly higher rates of gastritis, reflux, prescription laxative use, and medications used to stimulate gut motility.

After Diagnosis

Gut problems remain extremely common.

Dysbiosis is repeatedly reported.

Intestinal barrier disruption has been documented.

Blood-Brain Barrier disruption is well recognized in MS.

Central nervous system inflammation can damage myelin and oligodendrocytes.

When we look at that entire timeline, it becomes difficult to believe that the biological story of MS simply starts when a lesion suddenly appears in the brain.

The MRI May Be Showing Us a Later Part of the Disease Process

MRI can reveal lesions in the central nervous system which is used to diagnosis MS.

But an MRI does not show what was happening in the digestive system five or ten years earlier.

It does not show severe constipation.

It does not show reflux.

It does not show years of abnormal bowel motility.

And it does not tell us why those problems were already happening.

That is why the prediagnosis medical records matter so much.

They give us a window into what was happening before MS became obvious neurologically.

Why Are We Still Treating the Gut and Brain as Separate Problems?

Medicine is organized by specialty.

Neurologists focus on the brain and spinal cord.

Gastroenterologists focus on the digestive system.

But the body does not work as separate departments.

The nervous system affects the bowel and vise versa.

The gut microbiome interacts with the immune system.

The immune system affects blood vessels and barriers.

The vascular system affects the brain.

The gut and brain are continuously communicating.

The research gives us good reason to connect those dots.

I Lived This Pattern Before I Understood It

Years before my MS diagnosis, I had significant digestive problems.

At the time, no one connected those symptoms to what later happened neurologically.

Today, after living free of MS symptoms for over 37 years and spending decades studying the research, I see those early symptoms differently.

And now large population studies are documenting similar patterns in thousands of other people.

When the same digestive problems repeatedly appear years before MS diagnosis across large populations and different healthcare systems, we should pay attention.

MS may be diagnosed in the brain, but the biological process begins much earlier.

The Question We Should Be Asking

Instead of asking only:

Why is the immune system attacking myelin?

We should also be asking:

What is activating the immune system in the first place?

What role does gut dysbiosis play?

What role does intestinal permeability play?

What microbes may be involved?

What is happening before the Blood-Brain Barrier becomes compromised?

And what was already happening five, ten, or more years before the MS diagnosis?

These questions arise directly from the timeline now appearing in the medical literature.

They deserve serious investigation.

Where This Research Goes Next

In the next part of this series, I will look more closely at the specific disease-causing bacteria linked to MS.

The goal is to stop assuming MS begins only when a lesion appears on an MRI.

The medical records are telling us something more complex.

The body may have been struggling for years.

The gut may have been showing warning signs for years.

And by the time MS is diagnosed neurologically, we may be looking at a later stage of a much longer disease process.

There are real solutions to recover from parasites today!

To restore health, we must focus on treating the cause of inflammation, which are parasites. First, identify the enemy (parasites), then support the body and treat the parasites while following a holistic approach. When parasitic infections are treated effectively, we can overcome inflammation or disease.

If you’re frustrated with the fact that our standard of care STILL doesn’t offer a real solution for treating MS and other diseases, then click on the link below to watch Pam Bartha’s free masterclass training and discover REAL solutions that have allowed Pam and many others to live free from MS and other diseases.

CLICK Here to watch Pam’s masterclass training

References:

Yusuf FLA, Zhu F, Evans C, Fisk JD, Zhao Y, Marrie RA, Tremlett H. Gastrointestinal conditions in the multiple sclerosis prodrome. Ann Clin Transl Neurol. 2024;11(1):185-193. doi:10.1002/acn3.51945. Key finding: UBC study comparing MS patients to controls in the years before diagnosis found higher rates of doctor visits for gastritis and reflux, and higher use of laxatives and gut motility medications, with a stronger effect in men. https://doi.org/10.1002/acn3.51945

Tank P, Jacobs BM, Bestwick J, Dobson R. Pre-diagnostic features of multiple sclerosis in a diverse UK cohort: a nested case-control study. Ann Clin Transl Neurol. 2025;13(1):71-84. doi:10.1002/acn3.70175. Key finding: UK study of roughly 15,000 people with MS found chronic pain and bladder/bowel issues about twice as likely, and mood symptoms about 1.7 times as likely, in the years before diagnosis. https://doi.org/10.1002/acn3.70175

Wang X, Wan J, Wang M, Zhang Y, Wu K, Yang F. Multiple sclerosis and inflammatory bowel disease: a systematic review and meta-analysis. Ann Clin Transl Neurol. 2022;9(2):132-140. doi:10.1002/acn3.51495. Key finding: People with MS had 53% higher risk of IBD. People with IBD had 91% higher risk of MS, close to double. https://doi.org/10.1002/acn3.51495

Levinthal DJ, Rahman A, Nusrat S, O’Leary M, Heyman R, Bielefeldt K. Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis. Mult Scler Int. 2013;2013:319201. doi:10.1155/2013/319201. Key finding: 19.3% of MS patients met diagnostic criteria for IBS, well above general population rates. https://doi.org/10.1155/2013/319201

Camara-Lemarroy CR, Silva C, Greenfield J, Liu WQ, Metz LM, Yong VW. Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity. Mult Scler. 2020;26(11):1340-1350. doi:10.1177/1352458519863133. Key finding: Zonulin was significantly elevated in active MS versus inactive MS and healthy controls, and predicted worse one-year outcomes. Note: this same study found no significant difference in bacterial endotoxin markers between groups, which matters for the line in your post pairing zonulin with endotoxins. https://doi.org/10.1177/1352458519863133

Khanna L, Zeydan B, Kantarci OH, Camilleri M. Gastrointestinal motility disorders in patients with multiple sclerosis: a single-center study. Neurogastroenterol Motil. 2022;34(8):e14326. doi:10.1111/nmo.14326. Key finding: 82% of MS patients in this cohort had constipation, and 93% had bladder and/or bowel symptoms combined. https://doi.org/10.1111/nmo.14326

 

Blog Featured Image credit: ©kanchanachitkhamma via Canva.com